speb/financial-data huggingface dataset:
Financial ratios for CLUS.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -19672.14285714286
Net income: -17913.57142857143
Capital expenditures: 0
Operating cash flow: -200172.14285714287
Net tangible assets: -55945
Owner earnings: -17913.57142857143
Buffett classification: The Gruesome
Stock price: 0.0642857142857143
Shares outstanding: 21045750
Book value: -55945
Market cap (USD): 1352941.0714285716
Debt to equity: 0
Current ratio: 0.3142914674931274
Quick ratio: 0.3142914674931274
Free cash flow (dilution-adjusted): -200172.14285714287
Buyback yield (%): 0
Retained earnings: -1526800
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 97.99
Shares outstanding: 1991597732
Market cap (USD): 195156661758.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVX — annual report dated 2022-12-31
Total revenue: 235717000000
Gross profit: 73982000000
Operating income: 39950000000
Net income: 35608000000
Capital expenditures: 11974000000
Operating cash flow: 49602000000
Depreciation & amortization: 15295000000
Net tangible assets: 154560000000
Owner earnings: 38929000000
Return on net tangible assets (%): 25.186982401656316
Capex to operating income (%): 29.97246558197747
Buffett classification: The Good
Stock price: 155.28
P/E ratio: 8.684994827706134
Shares outstanding: 1991597732
Book value: 160242000000
P/B ratio: 1.9299265849462688
Market cap (USD): 309255295824.96
Debt to equity: 0.1456484567092273
Current ratio: 1.4716732927970066
Quick ratio: 1.2305893358278766
Effective tax rate (%): 28.31662439102951
Interest coverage ratio: 77.42248062015504
COGS to revenue (%): 68.61405838357012
SG&A to revenue (%): 1.8293122685253929
Free cash flow (dilution-adjusted): 37628000000
Buyback yield (%): 3.6393879593804543
Retained earnings: 190024000000
Inventory turnover: 19.611373832908935
Receivables turnover: 11.523122800156433
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.874640381922227
FCF margin (%): 15.963210120610732
Rule of 40 score: 15.963210120610732
Financial ratios for CVX — annual report dated 2023-12-31
Total revenue: 196913000000
Gross profit: 60391000000
Operating income: 26229000000
Net income: 21411000000
Capital expenditures: 15829000000
Operating cash flow: 35609000000
Depreciation & amortization: 17762000000
Net tangible assets: 156235000000
Owner earnings: 23344000000
Return on net tangible assets (%): 14.941594393061733
Capex to operating income (%): 60.34923176636548
Buffett classification: The Good
Stock price: 134.11
P/E ratio: 12.474577172412312
Shares outstanding: 1991597732
Book value: 161929000000
P/B ratio: 1.6494461883820688
Market cap (USD): 267093171838.52002
Debt to equity: 0.1286736779699745
Current ratio: 1.2749705499411
Quick ratio: 1.007998015996032
Effective tax rate (%): 27.62641968631693
Interest coverage ratio: 55.92537313432836
COGS to revenue (%): 69.33112592870964
SG&A to revenue (%): 2.102959174864026
Free cash flow (dilution-adjusted): 19780000000
Buyback yield (%): 5.593179300379818
Retained earnings: 200025000000
Inventory turnover: 15.852531351602416
Receivables turnover: 9.884694543446614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.435036229040781
FCF margin (%): 10.04504527380112
Revenue growth (%): -16.462113466572205
Rule of 40 score: -6.417068192771085
Financial ratios for CVX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 136.72
Shares outstanding: 1991597732
Market cap (USD): 272291241919.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVX — annual report dated 2024-12-31
Total revenue: 193414000000
Gross profit: 56926000000
Operating income: 18917000000
Net income: 17749000000
Capital expenditures: 16448000000
Operating cash flow: 31492000000
Depreciation & amortization: 17711000000
Net tangible assets: 147740000000
Owner earnings: 19012000000
Return on net tangible assets (%): 12.868552863137944
Capex to operating income (%): 86.94824760797167
Buffett classification: The Gruesome
Stock price: 135.84
P/E ratio: 15.242472021797283
Shares outstanding: 1991597732
Book value: 153157000000
P/B ratio: 1.7664137839921128
Market cap (USD): 270538635914.88
Debt to equity: 0.1602342694098213
Current ratio: 1.0610249494268376
Quick ratio: 0.8256911665542819
Effective tax rate (%): 35.47226059768778
Interest coverage ratio: 31.846801346801346
COGS to revenue (%): 70.56779757411563
SG&A to revenue (%): 2.4993020153660024
Free cash flow (dilution-adjusted): 15044000000
Buyback yield (%): 5.62914052867167
Retained earnings: 205852000000
Inventory turnover: 15.041657482918227
Receivables turnover: 9.350899245793851
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.66242329883689
FCF margin (%): 7.77813395100665
Revenue growth (%): -1.7769268661794804
Rule of 40 score: 6.001207084827169
Financial ratios for CVX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 135.84
Shares outstanding: 1991597732
Market cap (USD): 270538635914.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVX — quarterly report dated 2025-03-31
Total revenue: 46101000000
Gross profit: 13368000000
Operating income: 4297000000
Net income: 3512000000
Capital expenditures: 3927000000
Operating cash flow: 5189000000
Depreciation & amortization: 4235000000
Net tangible assets: 144676000000
Owner earnings: 3820000000
Return on net tangible assets (%): 2.640382648124084
Capex to operating income (%): 91.38934140097743
Buffett classification: The Gruesome
Stock price: 158.63
P/E ratio: 22.489119321409454
Shares outstanding: 1991597732
Book value: 150080000000
P/B ratio: 2.1050582904261725
Market cap (USD): 315927148227.16
Debt to equity: 0.19776785714285713
Current ratio: 1.0804436726233824
Quick ratio: 0.8236793456949191
Effective tax rate (%): 37.09475192548809
Interest coverage ratio: 20.2688679245283
COGS to revenue (%): 71.00279820394351
SG&A to revenue (%): 2.6485325697924123
Free cash flow (dilution-adjusted): 1262000000
Buyback yield (%): 1.2398427998291472
Retained earnings: 206359000000
Inventory turnover: 3.5707428820770155
Receivables turnover: 2.3569018404907975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.947030970343687
FCF margin (%): 2.7374677338886357
Rule of 40 score: 2.7374677338886357
Financial ratios for CVX — quarterly report dated 2025-06-30
Total revenue: 44375000000
Gross profit: 13173000000
Operating income: 4057000000
Net income: 2515000000
Capital expenditures: 3712000000
Operating cash flow: 8576000000
Depreciation & amortization: 4409000000
Net tangible assets: 141849000000
Owner earnings: 3212000000
Return on net tangible assets (%): 2.2643797277386515
Capex to operating income (%): 91.49617944293813
Buffett classification: The Gruesome
Stock price: 137.43
P/E ratio: 45.413186711259335
Shares outstanding: 1991597732
Book value: 147258000000
P/B ratio: 1.8586784847598095
Market cap (USD): 273705276308.76
Debt to equity: 0.20010457835907047
Current ratio: 0.9960949837769547
Quick ratio: 0.7430441898527005
Effective tax rate (%): 39.35374969857728
Interest coverage ratio: 14.806569343065693
COGS to revenue (%): 70.31436619718309
SG&A to revenue (%): 2.003380281690141
Free cash flow (dilution-adjusted): 4864000000
Buyback yield (%): 0.9491961700691739
Retained earnings: 205905000000
Inventory turnover: 3.540451605582662
Receivables turnover: 2.5123138764649267
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8783016116263027
FCF margin (%): 10.961126760563381
Revenue growth (%): -3.7439534934166288
Rule of 40 score: 7.217173267146753
Financial ratios for CVX — quarterly report dated 2025-09-30
Total revenue: 48169000000
Gross profit: 14990000000
Operating income: 4297000000
Net income: 3613000000
Capital expenditures: 4444000000
Operating cash flow: 9385000000
Depreciation & amortization: 5849000000
Net tangible assets: 185275000000
Owner earnings: 5018000000
Return on net tangible assets (%): 2.7084064228849005
Capex to operating income (%): 103.4209913893414
Buffett classification: The Gruesome
Stock price: 150.71
P/E ratio: 31.136275330883816
Shares outstanding: 1991597732
Book value: 195600000000
P/B ratio: 1.534528088904499
Market cap (USD): 300153694189.72003
Debt to equity: 0.21239263803680983
Current ratio: 1.152063599458728
Quick ratio: 0.8578597203428056
Effective tax rate (%): 33.26560768378278
Interest coverage ratio: 11.613513513513514
COGS to revenue (%): 68.88040025742697
SG&A to revenue (%): 3.163860574228238
Free cash flow (dilution-adjusted): 4941000000
Buyback yield (%): 0.8548953585019321
Retained earnings: 206006000000
Inventory turnover: 3.1792832502874666
Receivables turnover: 2.692961368591715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.476485161272588
FCF margin (%): 10.257634578255724
Revenue growth (%): 8.549859154929578
Rule of 40 score: 18.807493733185304
Financial ratios for CVX — annual report dated 2025-12-31
Total revenue: 184432000000
Gross profit: 56086000000
Operating income: 16674000000
Net income: 12485000000
Capital expenditures: 17347000000
Operating cash flow: 33939000000
Depreciation & amortization: 20457000000
Net tangible assets: 181882000000
Owner earnings: 15595000000
Return on net tangible assets (%): 8.574240441604996
Capex to operating income (%): 104.03622406141298
Buffett classification: The Gruesome
Stock price: 149.56
P/E ratio: 23.857697781171005
Shares outstanding: 1991597732
Book value: 192176000000
P/B ratio: 1.5499508616992757
Market cap (USD): 297863356797.92
Debt to equity: 0.2120868370660228
Current ratio: 1.1547009315002845
Quick ratio: 0.8638392188576391
Effective tax rate (%): 36.762396798865424
Interest coverage ratio: 13.700903861955629
COGS to revenue (%): 69.58987594343715
SG&A to revenue (%): 2.779344148520864
Free cash flow (dilution-adjusted): 16592000000
Buyback yield (%): 4.055215159679671
Retained earnings: 205365000000
Inventory turnover: 13.216558541859747
Receivables turnover: 10.203706777316736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7372903225806455
FCF margin (%): 8.996269627830312
Revenue growth (%): -4.6439244315302926
Rule of 40 score: 4.3523451963000195
Financial ratios for CVX — quarterly report dated 2025-12-31
Total revenue: 45787000000
Gross profit: 14555000000
Operating income: 4023000000
Net income: 2845000000
Capital expenditures: 5264000000
Operating cash flow: 10789000000
Depreciation & amortization: 5964000000
Net tangible assets: 181882000000
Owner earnings: 3545000000
Return on net tangible assets (%): 1.949065877876865
Capex to operating income (%): 130.84762614963955
Buffett classification: The Gruesome
Stock price: 149.56
P/E ratio: 23.857697781171005
Shares outstanding: 1991597732
Book value: 192176000000
P/B ratio: 1.5499508616992757
Market cap (USD): 297863356797.92
Debt to equity: 0.2120868370660228
Current ratio: 1.1547009315002845
Quick ratio: 0.8638392188576391
Effective tax rate (%): 38.138725809958686
Interest coverage ratio: 11.14404432132964
COGS to revenue (%): 68.21150108109289
SG&A to revenue (%): 3.2585668421167577
Free cash flow (dilution-adjusted): 5525000000
Buyback yield (%): 1.0065017839820891
Retained earnings: 205365000000
Inventory turnover: 3.216146637833385
Receivables turnover: 2.533167358229599
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.384258064516129
FCF margin (%): 12.06674383558652
Revenue growth (%): -4.94508916523075
Rule of 40 score: 7.1216546703557695
Financial ratios for DHC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.83
Shares outstanding: 242106926
Market cap (USD): 685162600.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHC — annual report dated 2022-12-31
Total revenue: 1283566000
Gross profit: 174496000
Operating income: -91219000
Net income: -15774000
Capital expenditures: 0
Operating cash flow: -40353000
Depreciation & amortization: 239525000
Net tangible assets: 2593260000
Owner earnings: 223751000
Buffett classification: The Gruesome
Stock price: 0.61
Shares outstanding: 242106926
Book value: 2638611000
P/B ratio: 0.05597082133743852
Market cap (USD): 147685224.85999998
Debt to equity: 1.155106607226302
Current ratio: 0.9493397257626062
Quick ratio: 0.9493397257626062
Interest coverage ratio: -0.43565618985304444
COGS to revenue (%): 86.40537377898761
SG&A to revenue (%): 2.05949674578479
Free cash flow (dilution-adjusted): -40353000
Buyback yield (%): 0.11578680275031002
Retained earnings: -1980817000
Receivables turnover: 147.26548875631025
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7317408685833096
FCF margin (%): -3.1438196399717664
Rule of 40 score: -3.1438196399717664
Financial ratios for DHC — annual report dated 2023-12-31
Total revenue: 1410308000
Gross profit: 236157000
Operating income: -74057000
Net income: -293572000
Capital expenditures: 0
Operating cash flow: 10483000
Depreciation & amortization: 284083000
Net tangible assets: 2302943000
Owner earnings: -9489000
Return on net tangible assets (%): -0.4120379879137261
Buffett classification: The Gruesome
Stock price: 3.62
Shares outstanding: 242106926
Book value: 2336891000
P/B ratio: 0.37503977383626363
Market cap (USD): 876427072.12
Debt to equity: 1.2053831351141324
Current ratio: 8.767167668670675
Quick ratio: 8.767167668670675
Interest coverage ratio: -0.38616608004171554
COGS to revenue (%): 83.27209375540662
SG&A to revenue (%): 1.8528576736429203
Free cash flow (dilution-adjusted): 10483000
Buyback yield (%): 0.04484115250449391
Retained earnings: -2283984000
Receivables turnover: 231.92040782765991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3673249638676297
FCF margin (%): 0.7433128082659958
Revenue growth (%): 9.874209818583541
Rule of 40 score: 10.617522626849537
Financial ratios for DHC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.11
Shares outstanding: 242106926
Market cap (USD): 995059465.8600001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 242106926
Market cap (USD): 547161652.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHC — annual report dated 2024-12-31
Total revenue: 1495427000
Gross profit: 258885000
Operating income: -52590000
Net income: -370255000
Capital expenditures: 0
Operating cash flow: 112223000
Depreciation & amortization: 285063000
Net tangible assets: 1932543000
Owner earnings: -85192000
Return on net tangible assets (%): -4.408284835059297
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 242106926
Book value: 1958843000
P/B ratio: 0.279328998168817
Market cap (USD): 547161652.76
Debt to equity: 1.486032316015117
Current ratio: 11.28935835192232
Quick ratio: 11.28935835192232
Interest coverage ratio: -0.22355986889928967
COGS to revenue (%): 82.68822215995833
SG&A to revenue (%): 1.7732727842950542
Free cash flow (dilution-adjusted): 112223000
Buyback yield (%): 0.1652162565559979
Retained earnings: -2663866000
Receivables turnover: 368.60414099087996
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0313989291808037
FCF margin (%): 7.504411783390295
Revenue growth (%): 6.0354901198887045
Rule of 40 score: 13.539901903278999
Financial ratios for DHC — quarterly report dated 2025-03-31
Total revenue: 386864000
Gross profit: 72538000
Operating income: -4787000
Net income: -8986000
Capital expenditures: 0
Operating cash flow: -3243000
Depreciation & amortization: 68351000
Net tangible assets: 1923744000
Owner earnings: 59365000
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 242106926
Book value: 1948051000
P/B ratio: 0.29454742951801566
Market cap (USD): 573793414.62
Debt to equity: 1.437535772934076
Current ratio: 14.348546176983922
Quick ratio: 14.348546176983922
Interest coverage ratio: -0.08277567394649928
COGS to revenue (%): 81.24974151122876
SG&A to revenue (%): 2.326398941229993
Free cash flow (dilution-adjusted): -3243000
Buyback yield (%): 0.0010456725098480879
Retained earnings: -2675265000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09633895857324155
FCF margin (%): -0.8382790851565408
Rule of 40 score: -0.8382790851565408
Financial ratios for DHC — quarterly report dated 2025-06-30
Total revenue: 382712000
Gross profit: 70132000
Operating income: -7311000
Net income: -91639000
Capital expenditures: 0
Operating cash flow: 53020000
Depreciation & amortization: 66294000
Net tangible assets: 1831842000
Owner earnings: -25345000
Return on net tangible assets (%): -1.3835800249148125
Buffett classification: The Gruesome
Stock price: 3.55
Shares outstanding: 242106926
Book value: 1854973000
P/B ratio: 0.4633380579124332
Market cap (USD): 859479587.3
Debt to equity: 1.4213198790494526
Current ratio: 8.470190449903395
Quick ratio: 8.470190449903395
Interest coverage ratio: -0.14356124572909712
COGS to revenue (%): 81.67499320637972
SG&A to revenue (%): 2.9204728359706515
Free cash flow (dilution-adjusted): 53020000
Buyback yield (%): 0.011983996074132244
Retained earnings: -2769317000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.15464974086490899
FCF margin (%): 13.853759484939065
Revenue growth (%): -1.07324537822077
Rule of 40 score: 12.780514106718295
Financial ratios for DHC — quarterly report dated 2025-09-30
Total revenue: 388706000
Gross profit: 63319000
Operating income: -14794000
Net income: -164040000
Capital expenditures: 0
Operating cash flow: -49285000
Depreciation & amortization: 65353000
Net tangible assets: 1666946000
Owner earnings: -98687000
Return on net tangible assets (%): -5.920227769825777
Buffett classification: The Gruesome
Stock price: 4.39
Shares outstanding: 242106926
Book value: 1688730000
P/B ratio: 0.62937793794153
Market cap (USD): 1062849405.1399999
Debt to equity: 1.6126704683401136
Current ratio: 15.594162335065974
Quick ratio: 15.594162335065974
Interest coverage ratio: -0.29790575916230366
COGS to revenue (%): 83.71031062036603
SG&A to revenue (%): 3.290147309277449
Free cash flow (dilution-adjusted): -49285000
Buyback yield (%): 0.08975871796948863
Retained earnings: -2935771000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.31787969046588693
FCF margin (%): -12.679248583762535
Revenue growth (%): 1.5661907648571247
Rule of 40 score: -11.11305781890541
Financial ratios for DHC — quarterly report dated 2025-12-31
Total revenue: 379571000
Gross profit: 72524000
Operating income: -2020000
Net income: -21221000
Capital expenditures: 0
Operating cash flow: -20110000
Depreciation & amortization: 62038000
Net tangible assets: 1644905000
Owner earnings: 40817000
Buffett classification: The Gruesome
Stock price: 4.83
Shares outstanding: 242106926
Book value: 1665568000
P/B ratio: 0.7020886884114008
Market cap (USD): 1169376452.58
Debt to equity: 1.4414446002805048
Current ratio: 2.620352767215885
Quick ratio: 2.620352767215885
Interest coverage ratio: -0.043111727670472735
COGS to revenue (%): 80.89316623240448
SG&A to revenue (%): 3.302675915704835
Free cash flow (dilution-adjusted): -20110000
Buyback yield (%): 0.007012284180948151
Retained earnings: -2959413000
Receivables turnover: 95.53762899572112
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.04692826619571132
FCF margin (%): -5.298086523996829
Revenue growth (%): -2.3501052209124635
Rule of 40 score: -7.648191744909292
Financial ratios for DHC — annual report dated 2025-12-31
Total revenue: 1537853000
Gross profit: 278513000
Operating income: -28912000
Net income: -285886000
Capital expenditures: 0
Operating cash flow: -19618000
Depreciation & amortization: 262036000
Net tangible assets: 1644905000
Owner earnings: -23850000
Return on net tangible assets (%): -1.4499317589769622
Buffett classification: The Gruesome
Stock price: 4.83
Shares outstanding: 242106926
Book value: 1665568000
P/B ratio: 0.7020886884114008
Market cap (USD): 1169376452.58
Debt to equity: 1.4414446002805048
Current ratio: 2.620352767215885
Quick ratio: 2.620352767215885
Interest coverage ratio: -0.1413803557981007
COGS to revenue (%): 81.88949138831865
SG&A to revenue (%): 2.958800353479819
Free cash flow (dilution-adjusted): -19618000
Buyback yield (%): 0.09791543155104432
Retained earnings: -2959413000
Receivables turnover: 387.0760130883463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6716782337873295
FCF margin (%): -1.2756745930852949
Revenue growth (%): 2.8370492173807214
Rule of 40 score: 1.5613746242954265
Financial ratios for DIBS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.51
Shares outstanding: 35333511
Market cap (USD): 442022222.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIBS — annual report dated 2022-12-31
Total revenue: 96849000
Gross profit: 67179000
Operating income: -29628000
Net income: -22538000
Capital expenditures: 93000
Operating cash flow: -27914000
Depreciation & amortization: 5251000
Net tangible assets: 143947000
Owner earnings: -17380000
Return on net tangible assets (%): -12.073888306112666
Buffett classification: The Gruesome
Stock price: 5.08
Shares outstanding: 35333511
Book value: 148022000
P/B ratio: 1.212618636959371
Market cap (USD): 179494235.88
Debt to equity: 0.16516463768899217
Current ratio: 6.23658349328215
Quick ratio: 6.23658349328215
Interest coverage ratio: -2693.4545454545455
COGS to revenue (%): 30.635318898491466
R&D to revenue (%): 25.23206228252228
SG&A to revenue (%): 74.724571239765
Free cash flow (dilution-adjusted): -41092000
Buyback yield (%): 0
Retained earnings: -291020000
Receivables turnover: 28.088457076566126
Capitalized R&D asset: 24437000
ROCI (R&D-adjusted, %): -6.868091782837153
FCF margin (%): -42.428935765986225
Rule of 40 score: -42.428935765986225
Financial ratios for DIBS — annual report dated 2023-12-31
Total revenue: 84684000
Gross profit: 59573000
Operating income: -27298000
Net income: -22699000
Capital expenditures: 1794000
Operating cash flow: -13556000
Depreciation & amortization: 4874000
Net tangible assets: 130172000
Owner earnings: -19619000
Return on net tangible assets (%): -15.07159757858833
Buffett classification: The Gruesome
Stock price: 4.68
Shares outstanding: 35333511
Book value: 134288000
P/B ratio: 1.2313894873704276
Market cap (USD): 165360831.48
Debt to equity: 0.16322381746693673
Current ratio: 5.33689414991519
Quick ratio: 5.33689414991519
COGS to revenue (%): 29.652590808181
R&D to revenue (%): 25.558547069103966
SG&A to revenue (%): 77.02399508761985
Free cash flow (dilution-adjusted): -27713000
Buyback yield (%): 2.040386450528992
Retained earnings: -313719000
Receivables turnover: 25.561122849381224
Capitalized R&D asset: 38016790
ROCI (R&D-adjusted, %): -10.995200171226747
Rosenberg metric: -0.31124933502475755
FCF margin (%): -32.72519011855841
Revenue growth (%): -12.560790508936591
Rule of 40 score: -45.285980627495
Financial ratios for DIBS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.41
Shares outstanding: 35333511
Market cap (USD): 155820783.51
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIBS — annual report dated 2024-12-31
Total revenue: 88257000
Gross profit: 63426000
Operating income: -23195000
Net income: -18633000
Capital expenditures: 1922000
Operating cash flow: -2910000
Depreciation & amortization: 5409000
Net tangible assets: 95073000
Owner earnings: -15146000
Return on net tangible assets (%): -15.930916243307774
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 35333511
Book value: 99305000
P/B ratio: 1.2595602330194855
Market cap (USD): 125080628.94
Debt to equity: 0.22311061880066463
Current ratio: 3.930707333356759
Quick ratio: 3.930707333356759
COGS to revenue (%): 28.13487881981033
R&D to revenue (%): 23.981100649240286
SG&A to revenue (%): 74.16522202204924
Free cash flow (dilution-adjusted): -19608000
Buyback yield (%): 22.180093140807642
Retained earnings: -332352000
Receivables turnover: 26.559434246163107
Capitalized R&D asset: 43730690
ROCI (R&D-adjusted, %): -15.180637392603396
Rosenberg metric: 0.1780170024025134
FCF margin (%): -22.216934634080015
Revenue growth (%): 4.2192149638656655
Rule of 40 score: -17.99771967021435
Financial ratios for DIBS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 35333511
Market cap (USD): 125080628.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIBS — quarterly report dated 2025-03-31
Total revenue: 22545000
Gross profit: 16322000
Operating income: -6255000
Net income: -4806000
Capital expenditures: 319000
Operating cash flow: -96000
Depreciation & amortization: 1324000
Net tangible assets: 91980000
Owner earnings: -3801000
Return on net tangible assets (%): -4.1324200913242
Buffett classification: The Gruesome
Stock price: 3.04
Shares outstanding: 35333511
Book value: 96241000
P/B ratio: 1.1160926573913406
Market cap (USD): 107413873.44
Debt to equity: 0.2195841689093006
Current ratio: 3.742726715268788
Quick ratio: 3.742726715268788
COGS to revenue (%): 27.60257263251275
R&D to revenue (%): 24.892437347527167
SG&A to revenue (%): 71.27079174983366
Free cash flow (dilution-adjusted): -4465000
Buyback yield (%): 1.670175315856294
Retained earnings: -337158000
Receivables turnover: 4.815249893208031
Capitalized R&D asset: 5612000
ROCI (R&D-adjusted, %): -2.116397661606509
FCF margin (%): -19.804834774894655
Rule of 40 score: -19.804834774894655
Financial ratios for DIBS — quarterly report dated 2025-06-30
Total revenue: 22135000
Gross profit: 15898000
Operating income: -5717000
Net income: -4313000
Capital expenditures: 236000
Operating cash flow: -5143000
Depreciation & amortization: 1333000
Net tangible assets: 90543000
Owner earnings: -3216000
Return on net tangible assets (%): -3.5519035154567447
Buffett classification: The Gruesome
Stock price: 2.75
Shares outstanding: 35333511
Book value: 94865000
P/B ratio: 1.0242676988351869
Market cap (USD): 97167155.25
Debt to equity: 0.21885837769461866
Current ratio: 3.873544702350443
Quick ratio: 3.873544702350443
COGS to revenue (%): 28.177095098260672
R&D to revenue (%): 26.663654845267676
SG&A to revenue (%): 66.6275129884798
Free cash flow (dilution-adjusted): -8815000
Buyback yield (%): 0
Retained earnings: -341471000
Receivables turnover: 5.001129688206055
Capitalized R&D asset: 9662040
ROCI (R&D-adjusted, %): -3.021029607909557
Rosenberg metric: -0.07555238774055595
FCF margin (%): -39.82380844815903
Revenue growth (%): -1.8185850521179863
Rule of 40 score: -41.64239350027702
Financial ratios for DIBS — quarterly report dated 2025-09-30
Total revenue: 21972000
Gross profit: 16331000
Operating income: -4683000
Net income: -3506000
Capital expenditures: 25000
Operating cash flow: -1468000
Depreciation & amortization: 1357000
Net tangible assets: 89692000
Owner earnings: -2174000
Return on net tangible assets (%): -2.4238505106364
Buffett classification: The Gruesome
Stock price: 2.59
Shares outstanding: 35333511
Book value: 93998000
P/B ratio: 0.9735717088661461
Market cap (USD): 91513793.49
Debt to equity: 0.20925977148449967
Current ratio: 4.007211167669289
Quick ratio: 4.007211167669289
COGS to revenue (%): 25.67358456217003
R&D to revenue (%): 26.87966502821773
SG&A to revenue (%): 65.16020389586747
Free cash flow (dilution-adjusted): -4942000
Buyback yield (%): 0
Retained earnings: -344977000
Receivables turnover: 4.89572192513369
Capitalized R&D asset: 11712300
ROCI (R&D-adjusted, %): -3.788739802487382
Rosenberg metric: 0.07336496103015927
FCF margin (%): -22.49226288002913
Revenue growth (%): -0.7363903320533092
Rule of 40 score: -23.22865321208244
Financial ratios for DIBS — quarterly report dated 2025-12-31
Total revenue: 22968000
Gross profit: 16887000
Operating income: 722000
Net income: -1041000
Capital expenditures: 86000
Operating cash flow: 4271000
Depreciation & amortization: 1284000
Net tangible assets: 89275000
Owner earnings: 157000
Capex to operating income (%): 11.911357340720222
Buffett classification: The Great
Stock price: 5.99
Shares outstanding: 35333511
Book value: 93581000
P/B ratio: 2.2616528022782405
Market cap (USD): 211647730.89000002
Debt to equity: 0.19863006379500112
Current ratio: 4.1951929781387145
Quick ratio: 4.1951929781387145
COGS to revenue (%): 26.475966562173458
R&D to revenue (%): 26.088470916057123
SG&A to revenue (%): 55.84291187739464
Free cash flow (dilution-adjusted): 968000
Buyback yield (%): 0.7394362289730286
Retained earnings: -346018000
Receivables turnover: 9.522388059701493
Capitalized R&D asset: 11896680
ROCI (R&D-adjusted, %): 0.6526075712955661
Rosenberg metric: 0.09414155096512021
FCF margin (%): 4.21455938697318
Revenue growth (%): 4.533042053522665
Rule of 40 score: 8.747601440495846
Financial ratios for DIBS — annual report dated 2025-12-31
Total revenue: 89620000
Gross profit: 65438000
Operating income: -15933000
Net income: -13666000
Capital expenditures: 763000
Operating cash flow: -2436000
Depreciation & amortization: 5298000
Net tangible assets: 89275000
Owner earnings: -9131000
Return on net tangible assets (%): -10.227947353682442
Buffett classification: The Gruesome
Stock price: 5.99
Shares outstanding: 35333511
Book value: 93581000
P/B ratio: 2.2616528022782405
Market cap (USD): 211647730.89000002
Debt to equity: 0.19863006379500112
Current ratio: 4.1951929781387145
Quick ratio: 4.1951929781387145
COGS to revenue (%): 26.982816335639363
R&D to revenue (%): 26.123633117607675
SG&A to revenue (%): 64.67194822584244
Free cash flow (dilution-adjusted): -17254000
Buyback yield (%): 1.5870711138149542
Retained earnings: -346018000
Receivables turnover: 37.1558872305141
Capitalized R&D asset: 44735070
ROCI (R&D-adjusted, %): -9.572716934668415
Rosenberg metric: 0.09506260335459485
FCF margin (%): -19.25239901807632
Revenue growth (%): 1.544353422391425
Rule of 40 score: -17.708045595684897
Financial ratios for ECBK — annual report dated 2022-12-31
Total revenue: 25043000
Net income: 2720000
Capital expenditures: 216000
Operating cash flow: 7770000
Depreciation & amortization: 302000
Net tangible assets: 162730000
Owner earnings: 2806000
Return on net tangible assets (%): 1.7243286425367172
Buffett classification: The Gruesome
Stock price: 16.05
P/E ratio: 51.65485974264706
Shares outstanding: 8753970
Book value: 162730000
P/B ratio: 0.8634008388127573
Market cap (USD): 140501218.5
Debt to equity: 1.0692558225281141
Effective tax rate (%): 22.19679633867277
COGS to revenue (%): 0
SG&A to revenue (%): 45.25815597172863
Free cash flow (dilution-adjusted): 6995000
Buyback yield (%): 0
Retained earnings: 80076000
Receivables turnover: 9.514817629179332
Capitalized R&D asset: 0
FCF margin (%): 27.93195703390169
Rule of 40 score: 27.93195703390169
Financial ratios for ECBK — annual report dated 2023-12-31
Total revenue: 25842000
Net income: 4456000
Capital expenditures: 335000
Operating cash flow: 6434000
Depreciation & amortization: 279000
Net tangible assets: 164901000
Owner earnings: 4400000
Return on net tangible assets (%): 2.668267627243013
Buffett classification: The Gruesome
Stock price: 12.56
P/E ratio: 24.674565350089768
Shares outstanding: 8753970
Book value: 164901000
P/B ratio: 0.6667628649917224
Market cap (USD): 109949863.2
Debt to equity: 1.419033238124693
Effective tax rate (%): 25.54720133667502
COGS to revenue (%): 0
SG&A to revenue (%): 53.58331398498568
Free cash flow (dilution-adjusted): 5361000
Buyback yield (%): 2.0236496301525184
Retained earnings: 83854000
Receivables turnover: 6.861922464152947
Capitalized R&D asset: 0
FCF margin (%): 20.74529835152078
Revenue growth (%): 3.1905123188116438
Rule of 40 score: 23.935810670332422
Financial ratios for ECBK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.32
Shares outstanding: 8753970
Market cap (USD): 125356850.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECBK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.84
Shares outstanding: 8753970
Market cap (USD): 129908914.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECBK — annual report dated 2024-12-31
Total revenue: 26214000
Net income: 3991000
Capital expenditures: 60000
Operating cash flow: 6228000
Depreciation & amortization: 302000
Net tangible assets: 168268000
Owner earnings: 4233000
Return on net tangible assets (%): 2.5156298286067464
Buffett classification: The Gruesome
Stock price: 14.84
P/E ratio: 32.55046725131546
Shares outstanding: 8753970
Book value: 168268000
P/B ratio: 0.7720357691301971
Market cap (USD): 129908914.8
Debt to equity: 1.3906387429576628
Effective tax rate (%): 25.69353937814187
COGS to revenue (%): 0
SG&A to revenue (%): 57.980468451972236
Free cash flow (dilution-adjusted): 4368000
Buyback yield (%): 2.095314247055815
Retained earnings: 87845000
Receivables turnover: 6.529016189290162
Capitalized R&D asset: 0
FCF margin (%): 16.66285191119249
Revenue growth (%): 1.4395170652426281
Rule of 40 score: 18.10236897643512
Financial ratios for ECBK — quarterly report dated 2025-03-31
Total revenue: 6919000
Net income: 1297000
Capital expenditures: 18000
Operating cash flow: -631000
Depreciation & amortization: 75000
Net tangible assets: 168578000
Owner earnings: 1354000
Return on net tangible assets (%): 0.8031890282243234
Buffett classification: The Gruesome
Stock price: 15.15
P/E ratio: 25.563347243639164
Shares outstanding: 8753970
Book value: 168578000
P/B ratio: 0.7867138386978134
Market cap (USD): 132622645.5
Debt to equity: 1.3880814815693625
Effective tax rate (%): 24.63683904706566
COGS to revenue (%): 0
SG&A to revenue (%): 54.82006070241364
Free cash flow (dilution-adjusted): -1102000
Buyback yield (%): 0.5074548147209144
Retained earnings: 89142000
Receivables turnover: 1.5931383836058024
Capitalized R&D asset: 0
FCF margin (%): -15.927157103627692
Rule of 40 score: -15.927157103627692
Financial ratios for ECBK — quarterly report dated 2025-06-30
Total revenue: 8015000
Net income: 1440000
Capital expenditures: 50000
Operating cash flow: 1895000
Depreciation & amortization: 75000
Net tangible assets: 168277000
Owner earnings: 1465000
Return on net tangible assets (%): 0.8705883751195945
Buffett classification: The Gruesome
Stock price: 15.44
P/E ratio: 49.383009426379246
Shares outstanding: 8753970
Book value: 168277000
P/B ratio: 0.8032071929021791
Market cap (USD): 135161296.79999998
Debt to equity: 1.5736850549986034
Effective tax rate (%): 24.804177545691903
COGS to revenue (%): 0
SG&A to revenue (%): 44.80349344978166
Free cash flow (dilution-adjusted): 1421000
Buyback yield (%): 1.0787111654880186
Retained earnings: 90582000
Receivables turnover: 1.6785340314136126
Capitalized R&D asset: 0
FCF margin (%): 17.729257641921397
Revenue growth (%): 15.840439369851133
Rule of 40 score: 33.56969701177253
Financial ratios for ECBK — quarterly report dated 2025-09-30
Total revenue: 8797000
Net income: 2439000
Capital expenditures: 71000
Operating cash flow: 4025000
Depreciation & amortization: 74000
Net tangible assets: 169309000
Owner earnings: 2442000
Return on net tangible assets (%): 1.4423332486754985
Buffett classification: The Gruesome
Stock price: 15.87
P/E ratio: 26.840321464451314
Shares outstanding: 8753970
Book value: 169309000
P/B ratio: 0.8205441169695645
Market cap (USD): 138925503.9
Debt to equity: 1.5345610688150069
Effective tax rate (%): 25.092137592137593
COGS to revenue (%): 0
SG&A to revenue (%): 45.31090144367398
Free cash flow (dilution-adjusted): 3488000
Buyback yield (%): 1.4151469275325765
Retained earnings: 93021000
Receivables turnover: 1.675299942868025
Capitalized R&D asset: 0
FCF margin (%): 39.64988064112765
Revenue growth (%): 9.75670617592015
Rule of 40 score: 49.4065868170478
Financial ratios for ECBK — quarterly report dated 2025-12-31
Total revenue: 9512000
Net income: 2596000
Capital expenditures: 75000
Operating cash flow: 3931000
Depreciation & amortization: 73000
Net tangible assets: 171934000
Owner earnings: 2594000
Return on net tangible assets (%): 1.508718461735317
Buffett classification: The Gruesome
Stock price: 17.39
P/E ratio: 19.587176827071538
Shares outstanding: 8753970
Book value: 171934000
P/B ratio: 0.885406832272849
Market cap (USD): 152231538.3
Debt to equity: 1.6565368106366396
Effective tax rate (%): 25.55205047318612
COGS to revenue (%): 0
SG&A to revenue (%): 43.502943650126156
Free cash flow (dilution-adjusted): 3387000
Buyback yield (%): 0.33698667551334854
Retained earnings: 95617000
Receivables turnover: 1.824319140774837
Capitalized R&D asset: 0
FCF margin (%): 35.607653490328005
Revenue growth (%): 8.127770830965101
Rule of 40 score: 43.73542432129311
Financial ratios for ECBK — annual report dated 2025-12-31
Total revenue: 33243000
Net income: 7772000
Capital expenditures: 214000
Operating cash flow: 9220000
Depreciation & amortization: 297000
Net tangible assets: 171934000
Owner earnings: 7855000
Return on net tangible assets (%): 4.568613537752859
Buffett classification: The Gruesome
Stock price: 17.39
P/E ratio: 19.587176827071538
Shares outstanding: 8753970
Book value: 171934000
P/B ratio: 0.885406832272849
Market cap (USD): 152231538.3
Debt to equity: 1.6565368106366396
Effective tax rate (%): 25.11802678485403
COGS to revenue (%): 0
SG&A to revenue (%): 46.64741449327678
Free cash flow (dilution-adjusted): 7194000
Buyback yield (%): 3.0282818208899354
Retained earnings: 95617000
Receivables turnover: 6.375719217491369
Capitalized R&D asset: 0
FCF margin (%): 21.640646151069397
Revenue growth (%): 26.813916227969788
Rule of 40 score: 48.45456237903919
Financial ratios for EDR.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.21259842519685
Shares outstanding: 296068802
Market cap (USD): 1247218969.055118
Buyback yield (%): 0.1491822981709009
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDR.TO — annual report dated 2022-12-31
Total revenue: 156756617.6470588
Gross profit: 37728676.47058823
Operating income: 17402205.88235294
Net income: 4559558.823529411
Capital expenditures: 80415441.17647058
Operating cash flow: 40436029.4117647
Depreciation & amortization: 19182352.94117647
Net tangible assets: 232274999.99999997
Owner earnings: -56673529.411764696
Return on net tangible assets (%): -24.399323823814317
Capex to operating income (%): 462.0991253644315
Buffett classification: The Gruesome
Stock price: 3.2205882352941173
P/E ratio: 209.12455293662313
Shares outstanding: 296068802
Book value: 232274999.99999997
P/B ratio: 4.105115490512641
Market cap (USD): 953515700.5588235
Debt to equity: 0.04932983849012644
Current ratio: 2.774137898348784
Quick ratio: 2.410453278735142
Effective tax rate (%): 75.1452964046655
Interest coverage ratio: 29.95822784810127
COGS to revenue (%): 74.51088001726168
SG&A to revenue (%): 4.877831407811847
Free cash flow (dilution-adjusted): -43088235.294117644
Buyback yield (%): 0.14682506005716603
Retained earnings: -255946323.52941173
Inventory turnover: 8.28028565471226
Receivables turnover: 11.739482378854627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.8265991323610855
FCF margin (%): -27.48734690814254
Rule of 40 score: -27.48734690814254
Financial ratios for EDR.TO — annual report dated 2023-12-31
Total revenue: 157510606.06060606
Gross profit: 27450757.575757574
Operating income: 6484090.909090909
Net income: 4638636.363636363
Capital expenditures: 83500000
Operating cash flow: 8917424.242424242
Depreciation & amortization: 21809848.484848484
Net tangible assets: 292682575.75757575
Owner earnings: -57051515.151515156
Return on net tangible assets (%): -19.49262439140552
Capex to operating income (%): 1287.7672625306693
Buffett classification: The Gruesome
Stock price: 1.9696969696969697
P/E ratio: 125.71923651804673
Shares outstanding: 296068802
Book value: 292682575.75757575
P/B ratio: 1.9924856155572408
Market cap (USD): 583165822.1212121
Debt to equity: 0.022050468368617362
Current ratio: 1.7301868003571184
Quick ratio: 1.2621900968340085
Effective tax rate (%): 66.45482934312167
Interest coverage ratio: 10.412408759124087
COGS to revenue (%): 81.3932683705763
SG&A to revenue (%): 5.765364525717363
Free cash flow (dilution-adjusted): -83055303.03030303
Buyback yield (%): 0
Retained earnings: -258265151.5151515
Inventory turnover: 6.208379191430039
Receivables turnover: 8.13944566238647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0546712021951063
FCF margin (%): -52.72997489346557
Revenue growth (%): 0.48099303548694206
Rule of 40 score: -52.24898185797863
Financial ratios for EDR.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 73333.33333333333
Buffett classification: The Gruesome
Stock price: 3.9555555555555553
Shares outstanding: 296068802
Market cap (USD): 1171116594.5777776
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDR.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 69230.76923076923
Buffett classification: The Gruesome
Stock price: 3.685314685314685
Shares outstanding: 296068802
Market cap (USD): 1091106703.8741257
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDR.TO — annual report dated 2024-12-31
Total revenue: 153566433.56643358
Gross profit: 29090909.090909094
Operating income: 5384615.384615385
Net income: -22027972.027972028
Capital expenditures: 136573426.57342657
Operating cash flow: 13356643.356643356
Depreciation & amortization: 21748251.748251747
Net tangible assets: 338741258.74125874
Owner earnings: -136853146.85314685
Return on net tangible assets (%): -40.40049545829893
Capex to operating income (%): 2536.3636363636365
Buffett classification: The Gruesome
Stock price: 3.685314685314685
Shares outstanding: 296068802
Book value: 338741258.74125874
P/B ratio: 3.2210623173823283
Market cap (USD): 1091106703.8741257
Debt to equity: 0.2481420313790256
Current ratio: 1.9974651457541193
Quick ratio: 1.541191381495564
Interest coverage ratio: 9.625
COGS to revenue (%): 80.14571948998179
SG&A to revenue (%): 6.284153005464481
Free cash flow (dilution-adjusted): -125524475.52447553
Buyback yield (%): 0
Retained earnings: -260279720.27972028
Inventory turnover: 4.888888888888889
Receivables turnover: 21.320388349514563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2025612993909105
FCF margin (%): -81.73952641165756
Revenue growth (%): -2.504067880136825
Rule of 40 score: -84.2435942917944
Financial ratios for EDR.TO — quarterly report dated 2025-03-31
Total revenue: 44685314.685314685
Gross profit: 8951048.951048952
Operating income: 2937062.9370629373
Net income: -23006993.006993007
Capital expenditures: 29090909.090909094
Operating cash flow: 2377622.3776223776
Depreciation & amortization: 6643356.643356644
Net tangible assets: 316116083.91608393
Owner earnings: -45454545.45454545
Return on net tangible assets (%): -14.379067617012426
Capex to operating income (%): 990.4761904761905
Buffett classification: The Gruesome
Stock price: 4.293706293706293
Shares outstanding: 296068802
Book value: 316116083.91608393
P/B ratio: 4.021410308419939
Market cap (USD): 1271232478.5174823
Debt to equity: 0.2708573906195387
Current ratio: 1.1398414393302276
Quick ratio: 0.7707957326580173
Interest coverage ratio: 10.5
COGS to revenue (%): 79.34272300469483
SG&A to revenue (%): 6.416275430359937
Free cash flow (dilution-adjusted): -27062937.062937062
Buyback yield (%): 0
Retained earnings: -283260139.86013985
Inventory turnover: 1.298169248495711
Receivables turnover: 6.114832535885167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6750664217139937
FCF margin (%): -60.56338028169014
Rule of 40 score: -60.56338028169014
Financial ratios for EDR.TO — quarterly report dated 2025-06-30
Total revenue: 65794160.5839416
Gross profit: 5578102.189781021
Operating income: -3492700.729927007
Net income: -14930656.934306568
Capital expenditures: 39525547.44525547
Operating cash flow: 15740145.985401459
Depreciation & amortization: 11078102.189781021
Net tangible assets: 386194160.5839416
Owner earnings: -43378102.18978102
Return on net tangible assets (%): -11.232200436223978
Buffett classification: The Gruesome
Stock price: 4.897810218978102
Shares outstanding: 296068802
Book value: 386194160.5839415
P/B ratio: 3.7548180473873822
Market cap (USD): 1450088803.9562044
Debt to equity: 0.3054437274847568
Current ratio: 0.9280153452205643
Quick ratio: 0.6465299728926118
Interest coverage ratio: -4.212147887323944
COGS to revenue (%): 89.8122878253345
SG&A to revenue (%): 8.326122168230935
Free cash flow (dilution-adjusted): -25012408.759124085
Buyback yield (%): 0
Retained earnings: -310596350.3649635
Inventory turnover: 1.348800399866711
Receivables turnover: 1.2397089768804412
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6113711195182625
FCF margin (%): -38.016153009829374
Revenue growth (%): 47.23888831774099
Rule of 40 score: 9.222735307911613
Financial ratios for EDR.TO — quarterly report dated 2025-09-30
Total revenue: 105013669.06474821
Gross profit: 11158992.805755397
Operating income: 1305035.9712230216
Net income: -30184172.661870506
Capital expenditures: 24927338.129496403
Operating cash flow: 19461870.503597125
Depreciation & amortization: 17327338.129496403
Net tangible assets: 366046043.1654677
Owner earnings: -37784172.66187051
Return on net tangible assets (%): -10.322245894293285
Capex to operating income (%): 1910.0882028665933
Buffett classification: The Gruesome
Stock price: 7.841726618705037
Shares outstanding: 296068802
Book value: 366046043.1654676
P/B ratio: 6.34261904741315
Market cap (USD): 2321690605.611511
Debt to equity: 0.3126233284329526
Current ratio: 0.7876502430025493
Quick ratio: 0.5666183060657829
Interest coverage ratio: 1.819458375125376
COGS to revenue (%): 87.22399961635689
SG&A to revenue (%): 4.411210599510855
Free cash flow (dilution-adjusted): -6143165.4676259
Buyback yield (%): 0
Retained earnings: -336311510.79136693
Inventory turnover: 2.1820051413881747
Receivables turnover: 1.8484576030797284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.24089121782860604
FCF margin (%): -5.849872233145394
Revenue growth (%): 59.60940626451116
Rule of 40 score: 53.75953403136576
Financial ratios for EDR.TO — annual report dated 2025-12-31
Total revenue: 347810218.97810215
Gross profit: 60145985.40145985
Operating income: 28102189.781021897
Net income: -86934306.56934306
Capital expenditures: 123503649.63503648
Operating cash flow: 49197080.2919708
Depreciation & amortization: 53868613.13868613
Net tangible assets: 422700729.92700726
Owner earnings: -156569343.0656934
Return on net tangible assets (%): -37.04023484717665
Capex to operating income (%): 439.4805194805195
Buffett classification: The Gruesome
Stock price: 9.423357664233576
Shares outstanding: 296068802
Book value: 422700729.9270073
P/B ratio: 6.600325045449835
Market cap (USD): 2789962214.467153
Debt to equity: 0.420998100500777
Current ratio: 1.528901734104046
Quick ratio: 1.303829479768786
Interest coverage ratio: 6.111111111111112
COGS to revenue (%): 80.81846799580273
SG&A to revenue (%): 4.050367261280168
Free cash flow (dilution-adjusted): -77153284.67153284
Buyback yield (%): 0
Retained earnings: -358613138.68613136
Inventory turnover: 6.1813804173354745
Receivables turnover: 5.306236080178174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.015017207216602
FCF margin (%): -22.18258132214061
Revenue growth (%): 126.48843949849092
Rule of 40 score: 104.30585817635031